Division of Pediatric Infectious Diseases Archives
Jan. 5, 2023—Vanderbilt's Kathryn Edwards, MD, internationally recognized for her countless contributions to vaccine evaluation and implementation, public health advocacy, and the mentorship and training of new generations of experts in infectious disease over the past four decades, retired on Dec. 31, 2022.
Nov. 17, 2022—The Vanderbilt Antimicrobial Stewardship Program provides oversight of antimicrobial therapies for both inpatient and outpatient populations.
Mar. 7, 2022—Reeyan Ahmed is among the patients treated at Monroe Carell Jr. Children's Hospital at Vanderbilt who developed MIS-C following COVID-19 infection.
Dec. 7, 2021—Vanderbilt has partnered with the CDC to combat the crisis of antimicrobial resistance and other healthcare threats through a newly created Global Action in Healthcare Network (GAIHN).
Oct. 21, 2021— by Jessica Pasley In a large, prospective study of children with COVID-19 infection at Monroe Carell Jr. Children’s Hospital at Vanderbilt, researchers found that most children experienced brief and mild illness with a small minority requiring hospitalization. During the onset of the pandemic, medical teams were not sure how the infection would impact children....
Monroe Carell Jr. Children’s Hospital at Vanderbilt sees surge in rare MIS-C cases amid drop in COVID-19 numbers
Feb. 8, 2021—While the number of COVID-19 cases across the country is decreasing, pediatricians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are beginning to see a new post-surge trend: an increase in cases of multi-system inflammatory syndrome in children (MIS-C).
Jul. 14, 2020—An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial.